Developing countries are considered the fastest growing markets for health care, but many countries have poor or inconsistent systems in place for protecting the intellectual property of innovators. This can be a barrier to commercializing and providing access to medical innovation in these markets. How do you protect inventions? This panel will outline strategies that both for-profit and non-profit groups are taking to prepare for the globalization of their innovative products.

Learning Objectives:

  • Explore IPR issues facing developing countries
  • Discover how to attract biotechs with good IPRs to your country
  • Identify examples for how non-profit groups have been doing it for years

Ability Level: All

Session ID: 1896

myBIO Chatter

Speakers (3)

icon_7_100 Ruth Atherton Associate General Counsel The Bill & Melinda Gates Foundation
contact_9725 Edmund Pitcher Partner Goodwin Proctor, LLP
contact_5138 Yves Ribeill President and CEO Scynexis, Inc

Moderators (1)

contact_3721 Una Ryan Managing Partner Golden Seeds